Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure
- 1 August 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 58 (2) , 730-739
- https://doi.org/10.1046/j.1523-1755.2000.00219.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Localization and Expression of Tissue Kallikrein and Kallistatin in Human Blood VesselsJournal of Histochemistry & Cytochemistry, 1999
- Human Kallikrein Gene Delivery Attenuates Hypertension, Cardiac Hypertrophy, and Renal Injury in Dahl Salt-Sensitive RatsHuman Gene Therapy, 1998
- Gene Therapy in Hypertension: Adenovirus-Mediated Kallikrein Gene Delivery in Hypertensive RatsHuman Gene Therapy, 1997
- Hypotension in Transgenic Mice Overexpressing Human Bradykinin B 2 ReceptorHypertension, 1997
- Endothelial Function and Bradykinin in HumansDrugs, 1997
- High level expression of human tissue kallikrein in the circulation induces hypotension in transgenic miceImmunopharmacology, 1996
- Human tissue kallikrein induces hypotension in transgenic mice.Hypertension, 1994
- The Glandular Kallikrein Family of Enzymes: Tissue Specific Expression and Hormonal RegulationEndocrine Reviews, 1989
- A gene for high urinary kallikrein may protect against hypertension in Utah kindreds.Hypertension, 1989
- Urinary Kallikrein Excretion in Hypertensive ManCirculation Research, 1974